Vivo Bio Tech Limited (BOM:511509)

Vivo Bio Tech Statistics

Total Valuation

Vivo Bio Tech has a market cap or net worth of INR 798.50 million. The enterprise value is 1.33 billion.

Market Cap	798.50M
Enterprise Value	1.33B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Vivo Bio Tech has 21.33 million shares outstanding. The number of shares has decreased by -5.39% in one year.

Current Share Class	21.33M
Shares Outstanding	21.33M
Shares Change (YoY)	-5.39%
Shares Change (QoQ)	+17.32%
Owned by Insiders (%)	13.21%
Owned by Institutions (%)	n/a
Float	8.58M

Valuation Ratios

The trailing PE ratio is 7.10.

PE Ratio	7.10
Forward PE	n/a
PS Ratio	1.63
PB Ratio	1.02
P/TBV Ratio	1.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	15.69
EV / Sales	2.70
EV / EBITDA	6.12
EV / EBIT	10.87
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.69
Debt / EBITDA	2.49
Debt / FCF	n/a
Interest Coverage	1.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.88%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	2.82M
Profits Per Employee	485,822
Employee Count	161
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Vivo Bio Tech has paid 15.97 million in taxes.

Income Tax	15.97M
Effective Tax Rate	15.89%

Stock Price Statistics

The stock price has increased by +1.37% in the last 52 weeks. The beta is 0.31, so Vivo Bio Tech's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+1.37%
50-Day Moving Average	36.21
200-Day Moving Average	38.63
Relative Strength Index (RSI)	52.87
Average Volume (20 Days)	49,356

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vivo Bio Tech had revenue of INR 490.50 million and earned 84.53 million in profits. Earnings per share was 5.27.

Revenue	490.50M
Gross Profit	434.30M
Operating Income	122.03M
Pretax Income	100.50M
Net Income	84.53M
EBITDA	216.75M
EBIT	122.03M
Earnings Per Share (EPS)	5.27

Balance Sheet

The company has 12.81 million in cash and 540.25 million in debt, giving a net cash position of -527.44 million or -24.72 per share.

Cash & Cash Equivalents	12.81M
Total Debt	540.25M
Net Cash	-527.44M
Net Cash Per Share	-24.72
Equity (Book Value)	779.05M
Book Value Per Share	50.58
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 88.54%, with operating and profit margins of 24.88% and 17.23%.

Gross Margin	88.54%
Operating Margin	24.88%
Pretax Margin	20.49%
Profit Margin	17.23%
EBITDA Margin	44.19%
EBIT Margin	24.88%
FCF Margin	n/a

Dividends & Yields

Vivo Bio Tech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.39%
Shareholder Yield	n/a
Earnings Yield	10.59%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 7, 2005
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1